Back

Atrial fibrillation and excess risk of cardiovascular and non-cardiovascular diseases: population-based linked cohort study

29 August 2026 (17:30 - 17:40)
Organised by: Logo
Congress Presentation Part of: Shaping cardiovascular health: policy, prevention strategies, and population-level impact Public Health ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Lan Mu

Queen Mary University of London, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Sex differences in cardiovascular disease burden in Europe: insights and implications from the ESC Atlas
Associate Professor N. Conrad (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Implementation of a novel, coordinated innovation policy of a National Society of Cardiology
Doctor C. Ghossein (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Electronic nudges to increase influenza vaccination uptake in young and middle-aged patients with heart failure: a prespecified analysis of the NUDGE-FLU-CHRONIC trial
Doctor D. Modin (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
High-dose vs. standard-dose influenza vaccine in patients with heart failure: the FLUNITY-HD pooled analysis
Doctor N. Johansen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Population-level health and economic impact of a national cardiovascular prevention programme: a 10-year evaluation of the National Health Services’ Health Check
Doctor F. Re (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Shaping cardiovascular health: policy, prevention strategies, and population-level impact
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 17:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardiometabolic multimorbidity and lifetime risk of atrial fibrillation among men and women
28 August 2022
thumbnail
Congress Presentation
Long-term outcomes in patients with non-valvular atrial fibrillation and left atrial appendage closure in a large UK tertiary centre: 10-year experience
24 April 2021
thumbnail
Congress Presentation
Hypo- and hyperthyroidism in patients with new-onset atrial fibrillation: a nationwide study
30 August 2025
thumbnail
Congress Presentation
Is atrial fibrillation an independent predictor of mortality in patients with heart failure and a reduced left ventricular ejection fraction?
1 July 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources